Detalles de la búsqueda
1.
Rhabdomyolysis, acute kidney injury, and mortality in Ebola virus disease: retrospective analysis of cases from Eastern Democratic Republic of the Congo, 2019.
J Infect Dis;
2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696335
2.
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
N Engl J Med;
384(13): 1240-1247, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33789012
3.
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
N Engl J Med;
381(24): 2293-2303, 2019 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31774950
4.
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
Clin Trials;
19(6): 647-654, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35866633
5.
Antibody Use during an Outbreak of Ebola Virus Disease in the Democratic Republic of Congo, 2020.
N Engl J Med;
386(12): 1188-1191, 2022 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320651
6.
Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
J Infect Dis;
217(4): 529-537, 2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29329455
7.
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.
N Engl J Med;
382(14): 1366-1369, 2020 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32242365
8.
Shifting the Paradigm - Applying Universal Standards of Care to Ebola Virus Disease.
N Engl J Med;
380(15): 1389-1391, 2019 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30970184
9.
High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.
BMC Infect Dis;
16: 263, 2016 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27286990
10.
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial.
J Infect Dis;
211(4): 549-57, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25225676
11.
Exploring host-virus interaction to improve immunotherapy against Ebola virus.
Trends Pharmacol Sci;
44(12): 857-861, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845170
12.
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection.
Antiviral Res;
209: 105453, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379378
13.
Cost-effectiveness of incorporating Ebola prediction score tools and rapid diagnostic tests into a screening algorithm: A decision analytic model.
PLoS One;
18(10): e0293077, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37847703
14.
The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries.
Am J Trop Med Hyg;
109(4): 719-724, 2023 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580027
15.
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
J Virol;
85(9): 4222-33, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21325402
16.
Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species.
PLoS Pathog;
6(5): e1000904, 2010 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20502688
17.
Development of Ebola virus disease prediction scores: Screening tools for Ebola suspects at the triage-point during an outbreak.
PLoS One;
17(12): e0278678, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525443
18.
Virus kinetics and biochemical derangements among children with Ebolavirus disease.
EClinicalMedicine;
53: 101638, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105872
19.
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo.
EClinicalMedicine;
54: 101699, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263398
20.
Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Front Immunol;
12: 721328, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526994